Skip to content
Menu
About Us
Company Overview
Management
Board of Directors
Our Science
Overview of Assets
Science
Pipeline
Clinical Trials
Expanded Access Policy
Newsroom
Press Releases
Events & Presentations
Investor Relations
Corporate Governance
Financial Information
Annual Reports & Proxy Statements
Investor Contact Info
Contact
Close Menu
Our Science
Overview of Assets
Science
– Polyamines
– Polyamine Metabolic Inhibitor Technology
Pipeline
Clinical Trials
– Ivospemin
– Flynpovi
Expanded Access Policy
